MX 1121
Alternative Names: HYB 101400; MBI 1121; ORI 1001Latest Information Update: 20 Jan 2023
At a glance
- Originator Idera Pharmaceuticals
- Developer MIGENIX
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Human papillomavirus infections